Phenotype-Genotype Correlations of 13 Rare CYP21A2 Mutations Detected in 46 Patients Affected with 21-Hydroxylase Deficiency and in One Carrier
The DOI matches its Crossref record; 48 of the 56 references it cites were found in a registry or an index.
Abstract
Context: Steroid 21-hydroxylase deficiency is the most common enzymatic defect causing congenital adrenal hyperplasia with genotype/phenotype relationships for common mutations. Novel mutations of the CYP21A2 gene must be well studied to propose right genetic counseling for patients. Objective: Thirteen CYP21 mutations have been studied. A detailed description of phenotype was performed for all mutations (p.I77T, p.L167P, p.I230T, p.R233K, p.G291S, p.G292D, p.E320K, p.R341P, p.R354H, p.R369W, p.R408C, p.G424S, and p.R426H). In vitro and in silico studies were performed only for those not previously described (p.L167P, p.I230T, p.R233K, p.G292D, p.E320K, and p.R369W). Results: Regarding phenotype, patients with 10 of these mutations had a classical form. A patient with isolated p.I230T presented with nonclassical form and a patient with the association p.I230T + p.V281L in cis presented with a more severe phenotype. The p.R233K mutation was detected in a carrier partner. A patient with p.R369W presented with an intermediate form. Functional studies showed that all mutations except p.I230T and p.R369W decreased enzyme activity more than p.P30L: severity of p.R369W was intermediate between p.P30L and p.V281L, and finally p.I230T was less severe than p.V281L. Mutation analysis in a three-dimensional model structure of the CYP21 protein explained the observed in vitro effects, severe mutations being implicated in important functional domains of the protein. Conclusion: According to phenotype and functional studies, 11 of the mutations described, except the isolated p.R369W and p.I230T, may be responsible for a severe phenotype underlying the necessity to manage children having them. The p.I230T is a nonclassical mutation, and for the p.R369W, we need more cases to precise its severity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several reports in European, Mediterranean, Middle Eastern, and Chinese populations confirmed a high frequency of the pathogenic IVS2-13A/C > G and found it to comprise 20 to 25% of the CYP21A2 mutant alleles and to translate to the most severe SW forms of the disease when inherited in homozygosity [1, 4, 27, 39–43].”
From Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene (2023) · cites this paper as [42]
In the citing paper
“Tardy et al. demonstrated that a series of rare missense substitutions variably impair 21-hydroxylase activity, ranging from near-null to residual levels compatible with nonclassical CAH, by disrupting heme coordination, active-site geometry, or overall protein stability (37).”
From Evolution of molecular diagnostic strategies for 21-hydroxylase deficiency: from classical methods to advanced genomic techniques (2026) · cites this paper as [37]
In the citing paper
“A huge study of 3200 patients in France found the intron 2 mutation in 30%, deletions and large gene conversions in 25%, I172N in 17%, and Q318X in 7% of alleles causing classic CAH, and, in nonclassic CAH, V281L was found in 55%, intron 2 in 9%, large rearrangements in 8%, I172N in 4%, and Q318X in 3% (431).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [431]
Citations
Cites
SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling
Guex, N., & Peitsch, M. C. (1997) · ELECTROPHORESIS · doi:10.1002/elps.1150181505 · Cited by 11,241 · cited 1×
“Interaction of each mutant with heme, P, and oxidoreduction partners, were in silico analyzed with the Deep View program (Swiss Institute of Bioinformatics, Lausanne, Switzerland) (27).”
MethodCongenital Adrenal Hyperplasia
(1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172211 · Cited by 1,409
Congenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
Gotoh, O. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48462-1 · Cited by 1,194 · cited 1×
“Isoleucine 77 is localized in helix B, near the substrate recognition site 1 (38).”
BackgroundCrystal Structure of Hemoprotein Domain of P450BM-3, a Prototype for Microsomal P450's
Ravichandran, K. G., Boddupalli, S. S., Hasermann, C. A., Peterson, J. A., & Deisenhofer, J. (1993) · Science · doi:10.1126/science.8342039 · Cited by 877
Structure and function of cytochromes P450: a comparative analysis of three crystal structures
Hasemann, C. A., Kurumbail, R. G., Boddupalli, S. S., Peterson, J. A., & Deisenhofer, J. (1995) · Structure · doi:10.1016/s0969-2126(01)00134-4 · Cited by 692 · cited 1×
“3C); it is important for structural elaboration of the cysteine pocket; lacking any side chain, it enables the sharp turn in combination with glycine 430 (37) (Fig.”
BackgroundThe Protein Data Bank and the challenge of structural genomics.
Berman, H. M., Bhat, T. N., Bourne, P. E., Feng, Z., Gilliland, G. L., Weissig, H., & Westbrook, J. (2000) · Nature Structural Biology · doi:10.1038/80734 · Cited by 627 · cited 1×
“Homology modeling The model used for our study was the human CYP21A2, previously generated (25) and available at Protein Data Bank with identification 2GEG (26).”
MethodSpeiser, P. W., Dupont, J., Zhu, D., Serrat, J., Buegeleisen, M., Tusie-Luna, M. T., Lesser, M., New, M. I., & White, P. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115897 · Cited by 572
Higashi, Y., Yoshioka, H., Yamane, M., Gotoh, O., & Fujii-Kuriyama, Y. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.9.2841 · Cited by 555 · cited 1×
“The 21-hydroxylase gene locus has been characterized in detail (4) and genotype-phenotype correlations have been widely studied in various ethnic and racial groups (5–9).”
BackgroundKrone, N., Braun, A., Roscher, A. A., Knorr, D., & Schwarz, H. P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6441 · Cited by 397
Research works printed but not linked: 1
- Tardy, 2005, Detection of heterozygotes for 21-hydroxylase deficiency: validation of 21-deoxycortisol after ACTH test by sequencing of the entire CYP21 gene, Horm Res, 64, 41
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Human cytochromes P450 in health and disease
Nebert, D. W., Wikvall, K., & Miller, W. L. (2013) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0431 · Cited by 505
“A study of 3200 French patients [124] found an intron-2 mutation in 30 per cent, deletions and large gene conversions in 25 per cent, Ile172Asn in 17 per cent and Gln318Xaa in 7 per cent of alleles causing classic CAH; in non-classic CAH, Val281Leu was found in 55 per cent, intron-2 mutations in 9 per cent, large rear…”
BackgroundNew, M. I., Abraham, M., Gonzalez, B., Dumic, M., Razzaghy-Azar, M., Chitayat, D., Sun, L., Zaidi, M., Wilson, R. C., & Yuen, T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300057110 · Cited by 365
“J Clin Endocrinol Metab 95(3):1288–1300.”
Carmina, E., Dewailly, D., Escobar-Morreale, H. F., Kelestimur, F., Moran, C., Oberfield, S., Witchel, S. F., & Azziz, R. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx014 · Cited by 201
Congenital Adrenal Hyperplasia
Witchel, S. F., & Azziz, R. (2011) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2010.10.001 · Cited by 161
Structure-phenotype correlations of human CYP21A2 mutations in congenital adrenal hyperplasia
Haider, S., Islam, B., D’Atri, V., Sgobba, M., Poojari, C., Sun, L., Yuen, T., Zaidi, M., & New, M. I. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221133110 · Cited by 127
“Proc Natl Acad Sci USA 83(14):5111–5115.”
CYP21A2 mutation update: Comprehensive analysis of databases and published genetic variants
Simonetti, L., Bruque, C. D., Fernández, C. S., Benavides-Mori, B., Delea, M., Kolomenski, J. E., Espeche, L. D., Buzzalino, N. D., Nadra, A. D., & Dain, L. (2018) · Human Mutation · doi:10.1002/humu.23351 · Cited by 122
Baumgartner-Parzer, S., Witsch-Baumgartner, M., & Hoeppner, W. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-020-0653-5 · Cited by 110
Nonclassic Congenital Adrenal Hyperplasia
Witchel, S. F., & Azziz, R. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/625105 · Cited by 101
The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
Pignatelli, D., Carvalho, B. L., Palmeiro, A., Barros, A., Guerreiro, S. G., & Macut, D. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00432 · Cited by 95
“A greater diversity of clinical phenotypes can be observed in patients with less severe pathogenic variants where although the phenotype can be predicted to correspond to the less severely affected allele, the presence of a second allele with a severe or an intermediate pathogenic variant, can result in a more severe…”
BackgroundHuman Cytochrome P450 21A2, the Major Steroid 21-Hydroxylase
Pallan, P. S., Wang, C., Lei, L., Yoshimoto, F. K., Auchus, R. J., Waterman, M. R., Guengerich, F. P., & Egli, M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.646307 · Cited by 90
Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): An update
Trapp, C. M., & Oberfield, S. E. (2012) · Steroids · doi:10.1016/j.steroids.2011.12.009 · Cited by 81
“P453S and R339H are also associated with NCCAH [9]; R369W and I230T are two novel mutations associated with NCCAH [24].”
Backgroundde Carvalho, D. F., Miranda, M. C., Gomes, L. G., Madureira, G., Marcondes, J. A. M., Billerbeck, A. E. C., Rodrigues, A. S., Presti, P. F., Kuperman, H., Damiani, D., et al. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0171 · Cited by 75
Coulm, B. (2012) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2011.774 · Cited by 78
Hayashi, G. Y., Carvalho, D. F., de Miranda, M. C., Faure, C., Vallejos, C., Brito, V. N., Rodrigues, A. D. S., Madureira, G., Mendonca, B. B., & Bachega, T. A. S. S. (2017) · Clinical Endocrinology · doi:10.1111/cen.13292 · Cited by 52
Beyond the Caster Semenya Controversy: The Case of the Use of Genetics for Gender Testing in Sport
Wonkam, A., Fieggen, K. J., & Ramesar, R. (2010) · Journal of Genetic Counseling · doi:10.1007/s10897-010-9320-2 · Cited by 56
“OH Deficiency is a continuum of phenotypes (Goossens et al 2009; Tardy et al. 2010) with variable expression of CAH even within a family (Bidet et al. 2009).”
BackgroundNonclassic congenital adrenal hyperplasia
Witchel, S. F. (2012) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e3283534db2 · Cited by 42
Gricman, Ł., Vogel, C., & Pleiss, J. (2015) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24840 · Cited by 40
Minutolo, C., Nadra, A. D., Fernández, C., Taboas, M., Buzzalino, N., Casali, B., Belli, S., Charreau, E. H., Alba, L., & Dain, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015899 · Cited by 31
Barbaro, M., Soardi, F. C., Östberg, L. J., Persson, B., de Mello, M. P., Wedell, A., & Lajić, S. (2014) · Clinical Endocrinology · doi:10.1111/cen.12526 · Cited by 32
Molecular diagnosis of steroid 21-hydroxylase deficiency: A practical approach
Arriba, M., & Ezquieta, B. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.834549 · Cited by 30
“Pro31Leu] with a cis pseudogene-conversion in 5’ (26, 56, 66, 67), and those carrying the variant c.”
BackgroundXu, C., Jia, W., Cheng, X., Ying, H., Chen, J., Xu, J., Guan, Q., Zhou, X., Zheng, D., Li, G., et al. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.671 · Cited by 29
“4%, 18%, 24%–38%, and 54%–61% residual 21‐hydroxylase activity (Tardy et al., 2010).”
InfluentialTuran, I., Tastan, M., Boga, D. D., Gurbuz, F., Kotan, L. D., Tuli, A., & Yüksel, B. (2020) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2019.103782 · Cited by 25
Kocova, M., Anastasovska, V., & Falhammar, H. (2020) · Endocrine · doi:10.1007/s12020-020-02323-3 · Cited by 24
Prenatal Diagnosis of Congenital Adrenal Hyperplasia
Yau, M., Khattab, A., & New, M. I. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.01.001 · Cited by 26
Bruque, C. D., Delea, M., Fernández, C. S., Orza, J. V., Taboas, M., Buzzalino, N. D., Espeche, L. D., Solari, A. P., Luccerini, V., Alba, L. G., et al. (2016) · Scientific Reports · doi:10.1038/srep39082 · Cited by 24
Gorduza, D., Tardy-Guidollet, V., Robert, E., Gay, C.-L., Chatelain, P., David, M., Bretones, P., Lienhardt-Roussie, A., Brac de la Perriere, A., Morel, Y., et al. (2014) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2014.02.003 · Cited by 20
Self-citationCoeli‐Lacchini, F. B., Turatti, W., Elias, P. C. L., Elias, L. L. K., Martinelli, C. E., Moreira, A. C., Antonini, S. R. R., & de Castro, M. (2013) · Gene · doi:10.1016/j.gene.2013.03.082 · Cited by 18
Adachi, E., Nakagawa, R., Tsuji-Hosokawa, A., Gau, M., Kirino, S., Yogi, A., Nakatani, H., Takasawa, K., Yamaguchi, T., Kosho, T., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad577 · Cited by 16
Tantirukdham, N., Sahakitrungruang, T., Chaisiwamongkol, R., Pongpanich, M., Srichomthong, C., Assawapitaksakul, A., Buasong, A., Tongkobpetch, S., Yeetong, P., & Shotelersuk, V. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac187 · Cited by 14
Brønstad, I., Breivik, L., Methlie, P., Wolff, A. S. B., Bratland, E., Nermoen, I., Løvås, K., & Husebye, E. S. (2014) · Endocrine Connections · doi:10.1530/ec-14-0032 · Cited by 14
Lin, B., Zhang, H., & Zheng, Q. (2020) · Physical Chemistry Chemical Physics · doi:10.1039/d0cp00763c · Cited by 12
Characterization of Mutations Causing CYP21A2 Deficiency in Brazilian and Portuguese Populations
Prado, M. J., Singh, S., Ligabue‐Braun, R., Meneghetti, B. V., Rispoli, T., Kopacek, C., Monteiro, K. M., Zaha, A., Rossetti, M. L. R., & Pandey, A. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010296 · Cited by 14
“G425S, which has less than 2% of enzyme activity [4].”
BackgroundInfluentialSharma, A., Yadav, S., Birla, S., Marumudi, E., Khadgawat, R., Khurana, M. L., & Ammini, A. C. (2015) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.163191 · Cited by 13
Variants of the CYP21A2 and CYP21A1P genes in congenital adrenal hyperplasia
Lee, H.-H. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.12.030 · Cited by 12
“In addition, a mutation of V281L, the most common nonclassical disease appearing at a high frequency in patients in France, Argentine, Austria, Italy, Spain, Turkey, and Portugal [32–35], was not found in Taiwanese [36], Japanese [37], or Tunisian patients [38].”
BackgroundTaboas, M., Acuña, L. I. G., Scaia, M. F., Bruque, C. D., Buzzalino, N. D., Stivel, M., Ceballos, N. R., & Daín, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092181 · Cited by 12
Michelatto, D. D. P., Karlsson, L., Lusa, A. L. G., Silva, C. D. M., Östberg, L. J., Persson, B., Guerra‐Júnior, G., de Lemos‐Marini, S. H. V., Barbaro, M., de Mello, M. P., et al. (2016) · International Journal of Endocrinology · doi:10.1155/2016/4209670 · Cited by 12
3β-Hydroxysteroid Dehydrogenase Deficiency
Morel, Y., Roucher‐Boulez, F., Plotton, I., Simard, J., & Coll, M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416006-4.00008-9 · Cited by 12
Self-citationHypothalamic–Pituitary–Adrenal Axis: Congenital Adrenal Hyperplasia
Pasterski, V., & Hughes, I. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00070-5 · Cited by 5
Fanis, P., Skordis, N., Phylactou, L. A., & Neocleous, V. (2023) · HORMONES · doi:10.1007/s42000-022-00410-w · Cited by 4
Tardy-Guidollet, V., Menassa, R., Aubry, M. C., & Benachi, A. (2015) · Revue de médecine périnatale · doi:10.1007/s12611-015-0331-y · Cited by 5
Self-citationIn Silico Structural and Biochemical Functional Analysis of a Novel CYP21A2 Pathogenic Variant
Cohen, M., Pignatti, E., Dines, M., Mory, A., Ekhilevitch, N., Kolodny, R., Flück, C. E., & Tiosano, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165857 · Cited by 5
“[22] measured the relative activity of an R234K mutation in vitro and showed that it is comparable to the I231T mutant (which also manifests as non-classical CAH [19]).”
BackgroundKöprülü, Ö., Özkan, B., Acar, S., Nalbantoğlu, Ö., Özkaya, B., Arslan, G., Hazan, F., & Gürsoy, S. (2021) · SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital · doi:10.14744/semb.2021.28044 · Cited by 4
“[7,8,19,20] The first study on the molecular basis of CAH patients in Turkish population, included 56 patients.”
BackgroundImproda, N., Ponmani, C., Schoenmakers, N. A., Senniappan, S., Atterbury, A., Barnicoat, A. J., Chatterjee, K., & Dattani, M. (2017) · Hormone Research in Paediatrics · doi:10.1159/000465521 · Cited by 3
Karlsson, L., Michelatto, D. D. P., Lusa, A. L. G., Silva, C. D. M., Östberg, L. J., Persson, B., Guerra‐Júnior, G., de Lemos‐Marini, S. H. V., Baldazzi, L., Menabò, S., et al. (2019) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2019.07.009 · Cited by 4
Miranda, M. C. D., Oliveira, A. C. M. D., Soares, G. J., Batatinha, J. A. P., Latronico, A. C., Mendonca, B. B., & Bachega, T. A. S. S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1770274 · Cited by 2
“Tardy et al. demonstrated that a series of rare missense substitutions variably impair 21-hydroxylase activity, ranging from near-null to residual levels compatible with nonclassical CAH, by disrupting heme coordination, active-site geometry, or overall protein stability (37).”
Sridhar, S., Govindhan, R., Soundian, B., Poomarimuthu, M., Nallan, K., kumar, S. R., Eagappan, S., Natarajan, V., & Jayaraman, S. (2021) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_442_21 · Cited by 2
Hosomi, S. S., Salles, I. C., & Bachega, T. A. S. S. (2023) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000593 · Cited by 6
3β-Hydroxysteroid dehydrogenase deficiency
Roucher‐Boulez, F., Morel, Y., Ladjouze, A., Plotton, I., Simard, J., & Coll, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00005-8 · Cited by 3
Self-citationPodgórski, R., Podgórska, D., & Sumińska, M. (2023) · Pediatria Polska · doi:10.5114/polp.2023.133534 · Cited by 2
“Other NCAH-associated missense mutations include P453S, P30L, R339H, or R369W, and combinations of mutations (heterozygous vs. homozygous) can yield different phenotypes [36, 47, 48].”
BackgroundHiperplasia congénita da suprarrenal por deficiência de 21-hidroxilase: correlação genótipo-fenótipo
Fontes, N., Pereira, M., Nascimento, M., Oliveira, E., Espada, F., & Fonseca, M. (2012) · Endocrinology Insights · doi:10.1016/s1646-3439(12)70003-2 · Cited by 3
Shifman, B. M., Dzeranova, L. K., Pigarova, E. A., Tiulpakov, A. N., & Fedorova, N. S. (2019) · Obesity and metabolism · doi:10.14341/omet10032 · Cited by 3
Soveizi, M., Mahdieh, N., Setoodeh, A., Sayarifard, F., Abbasi, F., Bose, H. S., Rabbani, B., & Rabbani, A. (2020) · International Journal of Endocrinology · doi:10.1155/2020/4329791 · Cited by 2
“Comparison of in vitro 17-OHP and progesterone [38] and in silico predicted activities (using a bovine based model and a human crystal) of ΔΔGs mutants of p.”
BackgroundEllaithi, M. M. H., de la Piscina, I. M., de la Hoz, A. B., de Nanclares, G. P., Alasha, M. A., Hemaida, M. A., & Castaño, L. A. (2019) · The Open Pediatric Medicine Journal · doi:10.2174/1874309901909010007 · Cited by 3
Iezzi, M. L., Varriale, G., Zagaroli, L., Lasorella, S., Greco, M., Iapadre, G., & Verrotti, A. (2020) · Journal of Pediatric Genetics · doi:10.1055/s-0040-1705110 · Cited by 4
Kurzyńska, A., Skalniak, A., Franson, K., Bistika, V., Hubalewska–Dydejczyk, A., & Przybylik‐Mazurek, E. (2022) · HORMONES · doi:10.1007/s42000-022-00348-z · Cited by 5
Pignatelli, D., & Pereira, S. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-82591-1_2 · Cited by 1
Bindellini, D., Michelet, R., Mirasbekov, Y., Lao, Q., Sukin, C., Huisinga, W., Merke, D. P., & Kloft, C. (2025) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.70086 · Cited by 2
“The same trend was observed for the variants associated with NC and NCC phenotypes: For P30L, P453S, and V281L, the model predicted typical enzymatic activities were 45.9%, 78.6%, and 81.7% compared to genotype-expected values of 34.1%, 36.0%, and 65%, respectively [12, 32–34].”
InfluentialIntegrated mapping resolves pathogenicity of 11 CYP21A2 variants in congenital adrenal hyperplasia
Xu, Y., Matveeva, A., Jørgensen, F. S., & Pandey, A. V. (2026) · Journal of the Endocrine Society · doi:10.1210/jendso/bvag127 · Cited by 2
“While a strong genotype–phenotype correlation has been established for common mutations, the increasing application of next-generation sequencing in clinical practice has led to the identification of a growing number of rare variants [26].”
The History of Prenatal Diagnosis of Congenital Adrenal Hyperplasia
Mancenido, D., & New, M. I. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416006-4.00004-1 · Cited by 1
Congenital Adrenal Hyperplasia – The Main Effect of 21-Hydroxylase Deficiency
Carvalho, B., Carvalho, F., & Carvalho, D. M. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.107092 · Cited by 1
Tardy-Guidollet, V., Menassa, R., Benachi, A., & Sas, L. (2015)
Self-citationde Miranda, M. C. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2020.tde-29102020-162042
Itonaga, T., Akiba, K., & Hasegawa, Y. (2021) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.30.187
Prado, M. J., Singh, S., Ligabue‐Braun, R., Meneghetti, B. V., Rispoli, T., Kopacek, C., Monteiro, K. M., Zaha, A., Rossetti, M. L. R., & Pandey, A. V. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.07.471616
Functional importance of novel nucleotide variations in the CYP21A2 gene
Michelatto, D. D. P. (2016) · doi:10.47749/t/unicamp.2016.966507 · Cited by 1
(2012) · Elsevier eBooks · doi:10.1016/b978-3-437-41797-9.16001-7
Adrenal Glands - The Current Stage and New Perspectives of Diseases and Treatment
Păun, D. L., Cianci, P., & Restini, E. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102209 · Cited by 1
The history of prenatal diagnosis of congenital adrenal hyperplasia
New, M. I., & Lo, D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00025-3
Hyperplasie congénitale des surrénales : formes précoces
Levaillant, L., Bouhours‐Nouet, N., Rouleau, S., Amsellem‐Jager, J., Donzeau, A., Briet, C., & Coutant, R. (2025) · EMC - Pédiatrie - Maladies infectieuses · doi:10.1016/s1637-5017(25)85172-x
Hiperplasia suprarrenal congénita: formas precoces
Levaillant, L., Bouhours-Nouet, N., Rouleau, S., Amsellem-Jager, J., Donzeau, A., Briet, C., & Coutant, R. (2025) · EMC - Pediatría · doi:10.1016/s1245-1789(25)51124-1
Metadata
- Authors
- Tardy, V., Menassa, R., Sulmont, V., Lienhardt-Roussie, A., Lecointre, C., Brauner, R., David, M., & Morel, Y.
- Affiliations
- Hôpital Femme Mère Enfant (FR)
- Centre Hospitalier Universitaire de Reims (FR)
- Centre Hospitalier Universitaire de Limoges (FR)
- Centre Hospitalier Universitaire de Rouen (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Corresponding author
- Tardy, V.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2010-03-01
- Volume
- 95
- Issue
- 3
- Pages
- 1288-1300
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1980640153
- Cited by
- 73
- References
- 56
- Citations by year
- 2026: 2 · 2025: 3 · 2023: 5 · 2022: 6 · 2021: 6 · 2020: 7 · 2019: 6 · 2018: 1 · 2017: 3 · 2016: 7 · 2015: 5 · 2014: 4 · 2013: 7 · 2012: 4
- FWCI
- 2.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- CYP21A2 mutations, 21-hydroxylase deficiency, congenital adrenal hyperplasia, genotype-phenotype correlation, rare mutations, enzyme activity, endophenotypes, genetic counseling
- MeSH terms
- Adrenal Hyperplasia, Congenital, Animals, Cells, Cultured, Chlorocebus aethiops, Humans, Mutation, Phenotype, Protein Conformation, Steroid 21-Hydroxylase, Time Factors, Blotting, Western, 17-alpha-Hydroxyprogesterone, COS Cells, Genetic Predisposition to Disease, Genetic Association Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.